Clinical Trial

Comparing Treatment of Knee Osteoarthritis With Triamcinolone Injections Using 40mg With Landmark Guidance and 20mg With Ultrasound Guidance

Study acronym: PRECISION-Knee
Enrolling by Invitation Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether a lower dose of corticosteroid injection with ultrasound-guidance for the treatment of knee osteoarthritis can be as effective as a higher dose that is landmark-guided. With landmark-guided dosing, it may be reasonable to use a higher amount of corticosteroid in order to ensure a sufficient amount of the medication is administered, however these injections carry the risk of side effects. Alternatively, with the use of ultrasound, it may be reasonable to use less corticosteroid, possibly decreasing the risk of side effects and increasing patient satisfaction.
Trial Details
NCT Number NCT07544576
Lead Sponsor Sosi Dzhugarian
Conditions Knee Arthritis Osteoarthritis
Enrollment 140 participants
Start Date 2025-12-12
Primary Completion 2026-12-08 (estimated)
Study Completion 2026-12-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-22